Drug intelligence / Profile preview

Benvit M

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Benvit M is an oral multivitamin and multimineral dietary supplement manufactured by Benham Pharmaceuticals in Bangladesh. It is formulated as a sugar-coated tablet containing a comprehensive blend of essential vitamins (including Vitamin A, Vitamin D, Vitamin C, Vitamin E, and B-complex vitamins such as B1, B2, B3, B5, B6, B9, and B12) and key minerals (including iron, copper, magnesium, zinc, iodine, and potassium). Benvit M is indicated for the prevention and treatment of vitamin and mineral deficiencies resulting from restricted diets, poor food intake, chronic illness, or malabsorption, as well as to meet increased nutritional demands during pregnancy, lactation, and convalescence.

Brand names: Benvit M
Other names: multivitamin + multimineralmultivitamin and multimineral

Targets

RAR (Retinoic acid receptor)RXRA (Retinoid X receptor alpha)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Benvit M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benvit M.